Long-Term Safety and Effectiveness of Thyrotropin Alfa in Japanese Patients: A Post-Marketing Surveillance Study

被引：0
|
作者：
Rie Kanamori
Shiho Yamane
Takeshi Seto
机构：
[1] Sanofi K.K.,Sanofi Genzyme Medical, Oncology Medical
[2] Sanofi K.K.,Medical Affairs, Post
来源：
Advances in Therapy | 2021年 / 38卷
关键词：
Ablation; Diagnosis; Japanese; Post-marketing surveillance; Recombinant human thyrotropin alfa; Real-world evidence; Thyroid cancer; Thyroid-stimulating hormone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4949 / 4960
页数：11
相关论文
共 50 条
  • [1] Long-Term Safety and Effectiveness of Thyrotropin Alfa in Japanese Patients: A Post-Marketing Surveillance Study
    Kanamori, Rie
    Yamane, Shiho
    Seto, Takeshi
    [J]. ADVANCES IN THERAPY, 2021, 38 (09) : 4949 - 4960
  • [2] Long-term safety and effectiveness of denosumab in Japanese patients with osteoporosis: 3-year post-marketing surveillance study
    Sakae Tanaka
    Hideki Mizutani
    Eri Tsuruya
    Ryoko Fukuda
    Kiyoka Kuge
    Naoki Okubo
    [J]. Journal of Bone and Mineral Metabolism, 2021, 39 : 463 - 473
  • [3] Long-term safety and effectiveness of denosumab in Japanese patients with osteoporosis: 3-year post-marketing surveillance study
    Tanaka, Sakae
    Mizutani, Hideki
    Tsuruya, Eri
    Fukuda, Ryoko
    Kuge, Kiyoka
    Okubo, Naoki
    [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 2021, 39 (03) : 463 - 473
  • [4] Long-term safety and effectiveness of omalizumab in Japanese paediatric patients with severe allergic asthma: A post-marketing surveillance
    Nakamura, N.
    Kashitani, Y.
    Yoshisue, H.
    Nagasaki, M.
    Sasajima, T.
    [J]. ALLERGY, 2020, 75 : 364 - 365
  • [5] Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes and Renal Dysfunction: a Post-Marketing Surveillance Study
    Yamamoto, Fumiko
    Ikeda, Rie
    Ochiai, Kaori
    Hirase, Tetsuaki
    Hayashi, Naoyuki
    Okamura, Tomoo
    [J]. DIABETES THERAPY, 2020, 11 (02) : 523 - 533
  • [6] Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes and Renal Dysfunction: a Post-Marketing Surveillance Study
    Fumiko Yamamoto
    Rie Ikeda
    Kaori Ochiai
    Tetsuaki Hirase
    Naoyuki Hayashi
    Tomoo Okamura
    [J]. Diabetes Therapy, 2020, 11 : 523 - 533
  • [7] Long-term tolerability and effectiveness of raltegravir in Japanese patients: Results from post-marketing surveillance
    Kuroishi, Naho
    Watananbe, Asuka
    Sakuma, Ryuta
    Ruzicka, Daniel J.
    Hara, Mitsuyoshi
    [J]. PLOS ONE, 2019, 14 (01):
  • [8] Long-Term Safety and Effectiveness of Adalimumab in Japanese Patients with Noninfectious Intermediate, Posterior, or Panuveitis: Post-Marketing Surveillance of 251 Patients
    Kenichi Namba
    Toshikatsu Kaburaki
    Hidekazu Tsuruga
    Yohei Ogawa
    Eri Iwashita
    Hiroshi Goto
    [J]. Ophthalmology and Therapy, 2022, 11 : 1147 - 1161
  • [9] Long-Term Safety and Effectiveness of Adalimumab in Japanese Patients with Noninfectious Intermediate, Posterior, or Panuveitis: Post-Marketing Surveillance of 251 Patients
    Namba, Kenichi
    Kaburaki, Toshikatsu
    Tsuruga, Hidekazu
    Ogawa, Yohei
    Iwashita, Eri
    Goto, Hiroshi
    [J]. OPHTHALMOLOGY AND THERAPY, 2022, 11 (03) : 1147 - 1161
  • [10] Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan
    Tanaka, Tetsuhiro
    Nangaku, Masaomi
    Imai, Enyu
    Tsubakihara, Yoshiharu
    Kamai, Masatoshi
    Wada, Michihito
    Asada, Shinji
    Akizawa, Tadao
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2019, 23 (02) : 231 - 243
12345